# The Social Medwork

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-social-medwork

- Industry: Healthcare
- Headquarters: Netherlands
- Website: www.thesocialmedwork.com
- Total disclosed funding: $1.7M
- Latest round: Seed (Oct 3, 2018)
- Investors on record: 1

## About

The Social Medwork BV specializes in facilitating access to pharmaceuticals that are unavailable in patients' home countries, focusing on expediting the procurement process for newly approved medications.Founded in 2015 in the Netherlands, The Social Medwork BV assists patients in acquiring medications not accessible domestically. The company received its first funding in 2018, raising USD 1.7 mn in a Seed round led by Rubio Impact Ventures. The founder, Sjaak Vink, has a history of entrepreneurship, although further details about previous companies are not available.The Social Medwork BV specializes in providing access to medicines that are unavailable in a patient's home country. Their core offering facilitates the acquisition of pharmaceuticals, including newly approved drugs, for patients who cannot wait for local regulatory approvals. The company operates by allowing a patient's doctor to prescribe medications that are not yet accessible domestically. Upon receiving the prescription, The Social Medwork BV assists in the procurement process, handling necessary paperwork and providing estimated costs while ensuring the medication is delivered promptly. The company caters to a diverse clientele, including individual patients, healthcare practitioners, and hospitals, focusing primarily on markets in Europe, the Middle East, and Asia, where patients face significant barriers to accessing essential treatments.The Social Medwork BV generates revenue through direct transactions with patients and healthcare providers seeking to obtain medications not available locally. The business model is structured around a fee-for-service approach, where patients pay for the procurement services, which may include handling of prescriptions, paperwork, and shipping logistics. Revenue streams can include one-time transaction fees for individual medication requests, as well as potential partnerships with healthcare organizations requiring ongoing access to specific treatments for their patients. The company emphasizes transparency in its pricing, ensuring that patients are informed of costs before confirming orders. This approach not only supports patient access to crucial medications but also establishes a reliable revenue mechanism through its core services.Following the most recent Seed funding round of USD 1.7 mn completed in October 2018, The Social Medwork BV plans to utilize the funds to strengthen and scale-up its systems, recruit new staff, and enhance its service capabilities to assist a larger number of patients. The company is focusing on expanding its operations into new markets across Europe, the Middle East, and Asia, aiming to reach these regions by 2021. This strategic initiative is expected to broaden their patient base significantly and improve access to essential medications.

## Funding rounds

- Seed, Oct 3, 2018, $1.7M — Rubio Impact Ventures

## Investors

- Rubio Impact Ventures (https://capitalatlas.ai/funds/rubio-impact-ventures) — Seed